Some anecdotal users report improvements in digestion, pain reduction and symptom flares within 710 days
BPC 157 therapy can recover glaucomatous rats, normalize intraocular pressure, maintain retinal integrity, recover pupil function, recover retinal ischemia, and corneal injuries (i.e., maintain transparency after complete corneal abrasion, corneal ulceration, and counteract dry eye after lacrimal gland removal or corneal insensitivity) [2,45,86,111,112,113,114]
For example: A single 250mcg dose may clear within 24 hours Daily dosing for 46 weeks may result in sustained biological activity for days or even weeks after stopping The longer and more consistent your protocol, the more tissue-level activation continues beyond clearance
Single-vial format lets you test a compound without committing to a full sealed box, useful for short pilot protocols
If you are experiencing symptoms such as fatigue, weakness, or even neurological changes, its important to get to the root of the problem